HL-190

N/A

Report date: 2022/04/29 17:57:39

Base Information

Drug NameHL-190
Drug Alias NameHL-190
ClassificationOther
Mechanisms of ActionTumor necrosis factor inhibitors
TargetsTumor necrosis factor
Therapy Area/IndicationsUveitisMacular DegenerationDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSenju Pharmaceutical Co LtdHanAll Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHanAll Biopharma Co LtdSenju Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsUveitisMacular DegenerationDiabetic Retinopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A